Clinical Trial Update: Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA) [NA]

View source ↗

Summary

This clinical trial update discusses a gene therapy approach for ADA-SCID using an improved lentiviral vector called Ivlv-ADA, being developed by Shenzhen Geno-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenosine Deaminase Severe Combined Immunodeficiency

Drugs mentioned

• Ivlv-ADA

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID) | NA | Status: RECRUITING